Stocks News

LAST PRICE
327.5700
TODAY'S CHANGE (%)
Trending Up3.4700 (1.0707%)

Bid / Lots
324.0000/ 1
Ask / Lots
334.4000/ 1
Open / Previous Close
327.3000 / 324.1000
Day Range
Low 325.8500
High 335.5800
52 Week Range
Low 265.0000
High 413.7000
Volume
632,111
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Oct 29, 2024
- West to Participate in Upcoming Investor Conferences, from 6:00AM ET on Tuesday Oct 29, 2024 by PR Newswire
  6:00AM ET on Tuesday Oct 29, 2024 by PR Newswire
  Companies Mentioned: WST
  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences:
  https://mma.prnewswire.com/media/890850/west_pharma_large_Logo.jpg
- West to Participate in Upcoming Investor Conferences, from 6:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  6:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: WST
  
  West to Participate in Upcoming Investor Conferences
  
  PR Newswire
  
  EXTON, Pa., Oct. 29, 2024
  
  EXTON, Pa., Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences:
Oct 25, 2024
- Jefferies Adjusts Price Target on West Pharmaceutical Services to $393 From $345, from 12:16PM ET on Friday Oct 25, 2024 by MT Newswires
  12:16PM ET on Friday Oct 25, 2024 by MT Newswires
  Companies Mentioned: WST
  12:16 PM EDT, 10/25/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average rating of outperform and price targets ranging from $265 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and eco...
- UBS Raises Price Target on West Pharmaceutical Services to $350 From $310, Maintains Neutral Rating, from 11:10AM ET on Friday Oct 25, 2024 by MT Newswires
  11:10AM ET on Friday Oct 25, 2024 by MT Newswires
  Companies Mentioned: WST
  11:10 AM EDT, 10/25/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average outperform rating and price target range of $265 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic re...
- Stephens Adjusts Price Target on West Pharmaceutical Services to $380 From $340, from 9:16AM ET on Friday Oct 25, 2024 by MT Newswires
  9:16AM ET on Friday Oct 25, 2024 by MT Newswires
  Companies Mentioned: WST
  09:16 AM EDT, 10/25/2024 (MT Newswires) -- West Pharmaceutical Services (WST) has an average rating of outperform and price targets ranging from $265 to $470, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and eco...

Today
- DJ Insulet Is Maintained at Equal-Weight by Barclays, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: PODD
- DJ Insulet Is Maintained at Overweight by Morgan Stanley, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
  Companies Mentioned: PODD
- Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating, from 13 hours ago by MT Newswires
  13 hours ago by MT Newswires
  Companies Mentioned: PODD
Nov 8, 2024
- DJ Insulet Shares Gain After Raising FY Outlook, Beating Analysts' 3Q Estimates, from 1:43PM ET on Friday Nov 08, 2024 by Dow Jones
  1:43PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: PODD
- Wolfe Research Adjusts Price Target on Insulet to $265 From $220, from 12:53PM ET on Friday Nov 08, 2024 by MT Newswires
  12:53PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: PODD
- DJ Insulet Is Maintained at Buy by BTIG, from 12:53PM ET on Friday Nov 08, 2024 by Dow Jones
  12:53PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: PODD
- Leerink Partners Adjusts Price Target on Insulet to $278 From $262, from 12:50PM ET on Friday Nov 08, 2024 by MT Newswires
  12:50PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: PODD
- Jefferies Raises Price Target on Insulet to $300 From $260, from 12:50PM ET on Friday Nov 08, 2024 by MT Newswires
  12:50PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: PODD
- BTIG Raises Price Target on Insulet to $270 From $260, from 12:49PM ET on Friday Nov 08, 2024 by MT Newswires
  12:49PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: PODD
- Bernstein Adjusts Price Target on Insulet to $305 From $300, from 12:48PM ET on Friday Nov 08, 2024 by MT Newswires
  12:48PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: PODD

West Pharmaceutical Services Inc
NYSE:WSTUnited States

Search Criteria

Oct 29, 2024

West to Participate in Upcoming Investor Conferences, from 6:00AM ET on Tuesday Oct 29, 2024 by PR Newswire

West to Participate in Upcoming Investor Conferences, from 6:00AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 25, 2024

Jefferies Adjusts Price Target on West Pharmaceutical Services to $393 From $345, from 12:16PM ET on Friday Oct 25, 2024 by MT Newswires

UBS Raises Price Target on West Pharmaceutical Services to $350 From $310, Maintains Neutral Rating, from 11:10AM ET on Friday Oct 25, 2024 by MT Newswires

Stephens Adjusts Price Target on West Pharmaceutical Services to $380 From $340, from 9:16AM ET on Friday Oct 25, 2024 by MT Newswires

Peers Headlines

Today

DJ Insulet Is Maintained at Equal-Weight by Barclays, from 9 hours ago by Dow Jones

DJ Insulet Is Maintained at Overweight by Morgan Stanley, from 12 hours ago by Dow Jones

Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating, from 13 hours ago by MT Newswires

Nov 8, 2024

DJ Insulet Shares Gain After Raising FY Outlook, Beating Analysts' 3Q Estimates, from 1:43PM ET on Friday Nov 08, 2024 by Dow Jones

Wolfe Research Adjusts Price Target on Insulet to $265 From $220, from 12:53PM ET on Friday Nov 08, 2024 by MT Newswires

DJ Insulet Is Maintained at Buy by BTIG, from 12:53PM ET on Friday Nov 08, 2024 by Dow Jones

Leerink Partners Adjusts Price Target on Insulet to $278 From $262, from 12:50PM ET on Friday Nov 08, 2024 by MT Newswires

Jefferies Raises Price Target on Insulet to $300 From $260, from 12:50PM ET on Friday Nov 08, 2024 by MT Newswires

BTIG Raises Price Target on Insulet to $270 From $260, from 12:49PM ET on Friday Nov 08, 2024 by MT Newswires

Bernstein Adjusts Price Target on Insulet to $305 From $300, from 12:48PM ET on Friday Nov 08, 2024 by MT Newswires